4
Changes in Ownership
Ocugen, Inc. Filed Acc 0000899243-18-026060
Options or other derivatives
- Chief Medical Officer acquired 200,000 shares (grant or award)
- Chief Medical Officer returned 200,000 shares (to the company)
From the SEC's structured data for this filing
Trades in this filing
Kelley Lynne E · Chief Medical Officer
Table II: Derivative
2 lines| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2018-10-01 | Returned to the company : show line 1 in the form Employee Stock Option (Right to Buy) | −200,000 | 0 | D |
| 2018-10-01 | Grant or award : show line 2 in the form Employee Stock Option (Right to Buy) | +200,000 | 200,000 | D |
Loading xslF345X03/doc4.xml…